Genetics and Psychopathology in the 22q11 Deletion Syndrome

Status unconfirmed

Conditions studied: Chromosome 22q11.2 Deletion Syndrome

In brief

The purposes of this study are to: 1. study the nature and longitudinal course of psychiatric symptoms in children with the 22q11.2 deletion syndrome and 2. identify genes that contribute to the occurrence of these symptoms.

Key facts

Study ID

NCT00161109

Run by

UMC Utrecht

People needed

175

Starts

2002-10-01

Expected to finish

2012-10-01

Last updated by the study team

2006-10-13

Who can join

Age: 8 and older, up to 20. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 22q11.2 deletion confirmed with fluorescence in-situ hybridization (FISH)

You may not qualify if…

• None

Where it is running

• Children's Hospital of Philadelphia, Dpt of Genetics and Dpt of Child and Adolescent Psychiatry — Philadelphia, Pennsylvania, United States (enrolling)
• UMC Utrecht, Dpt of Child and Adolescent Psychiatry — Utrecht, Netherlands (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.